Phase 2 Hypoglycemia Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Zucara Therapeutics Inc.186 enrolled46 locationsNCT05762107
Recruiting
Phase 2
Restoration of Hypoglycemia Awareness With Metoclopramide
Hypoglycemia Unawareness
Simon Fisher36 enrolled2 locationsNCT03970720
Recruiting
Phase 1Phase 2
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
Metabolic DiseaseDiabetes Mellitus, Type 1Type 1 Diabetes+14 more
Otsuka Pharmaceutical Factory, Inc.13 enrolled1 locationNCT06575426
Recruiting
Phase 2
Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)
Postbariatric Hypoglycemia
MBX Biosciences10 enrolled4 locationsNCT07029412
Recruiting
Phase 2
Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)
PretermTransient; Hypoglycemia, NeonatalGlibenclamide Adverse Reaction
Assistance Publique - Hôpitaux de Paris35 enrolled1 locationNCT05687500
Recruiting
Phase 1Phase 2
A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1Impaired Hypoglycemic AwarenessSevere Hypoglycemia
EndoCell Therapeutics, Inc.21 enrolled1 locationNCT07126873